Back
Heron Therapeutics Stock Price Chart
Sell
48
HRTX
Heron Therapeutics
Last Price:
3.20
Seasonality Move:
3.23%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRTX is experiencing selling pressure, which indicates risk of future bearish movement.
Heron Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.97 | Buy |
| 20-day SMA: | 2.74 | Buy |
| 50-day SMA: | 2.78 | Buy |
| 200-day SMA: | 1.89 | Buy |
| 8-day EMA: | 2.98 | Buy |
| 20-day EMA: | 2.84 | Buy |
| 50-day EMA: | 2.73 | Buy |
| 200-day EMA: | 2.27 | Buy |
Heron Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 64.51 | Buy |
| Chaikin Money Flow: | -1783008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 2.98) | Buy |
| Bollinger Bands (100): | (2.21 - 2.91) | Buy |
Heron Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 3.20 while HRTX 8-day simple moving average is 2.97, which is a Buy signal.
- The stock price of HRTX is 3.20 while Heron Therapeutics 20-day SMA is 2.74, which makes it a Buy.
- Heron Therapeutics 50-day simple moving average is 2.78 while HRTX share price is 3.20, making it a Buy technically.
- HRTX stock price is 3.20 and Heron Therapeutics 200-day simple moving average is 1.89, creating a Buy signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
48
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a Sell
The current Heron Therapeutics [HRTX] share price is $3.20. The Score for HRTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
482.09M
Price in USD:
3.20
Share Volume:
3.15M
Heron Therapeutics 52-Week Range
52-Week High:
3.29
52-Week Low:
0.50
Sell
48
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?
The Heron Therapeutics stock price is 3.20 USD today. -
Will HRTX stock go up or go down?
Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Heron Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 3.20 while HRTX 8-day exponential moving average is 2.98, which is a Buy signal.
- The stock price of HRTX is 3.20 while Heron Therapeutics 20-day EMA is 2.84, which makes it a Buy.
- Heron Therapeutics 50-day exponential moving average is 2.73 while HRTX share price is 3.20, making it a Buy technically.
- HRTX stock price is 3.20 and Heron Therapeutics 200-day simple moving average is 2.27, creating a Buy signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.13 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
- HRTX Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Heron Therapeutics is a Buy
- Heron Therapeutics Relative Strength Index (RSI) is 64.51, which suggest Heron Therapeutics is overbought
- The Bollinger Bands (25) for Heron Therapeutics is (2.52 - 2.98), which suggest Heron Therapeutics is a Buy
- The Bollinger Bands (100) for Heron Therapeutics is (2.21 - 2.91), which suggest Heron Therapeutics is a Buy
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.